Header Logo

Connection

Hung Tseng to Herpes Zoster Vaccine

Back to Details
This is a "connection" page, showing publications Hung Tseng has written about Herpes Zoster Vaccine.
Hung Tseng
Connection Strength
8.875
Herpes Zoster Vaccine
  1. Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged =50 years in the United States. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2327145.
    View in: PubMed
    Score: 0.868
  2. Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):643-649.
    View in: PubMed
    Score: 0.798
  3. Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older. Vaccine. 2021 02 05; 39(6):926-932.
    View in: PubMed
    Score: 0.696
  4. Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. J Manag Care Spec Pharm. 2020 Dec; 26(12):1567-1575.
    View in: PubMed
    Score: 0.684
  5. Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. Vaccine. 2019 06 06; 37(26):3478-3484.
    View in: PubMed
    Score: 0.620
  6. Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization. BMC Health Serv Res. 2017 07 21; 17(1):503.
    View in: PubMed
    Score: 0.547
  7. Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged =60 Years. J Infect Dis. 2016 06 15; 213(12):1872-5.
    View in: PubMed
    Score: 0.495
  8. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Clin Infect Dis. 2016 Feb 15; 62(4):462-7.
    View in: PubMed
    Score: 0.490
  9. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. J Infect Dis. 2015 Oct 15; 212(8):1222-31.
    View in: PubMed
    Score: 0.472
  10. Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Clin Infect Dis. 2014 Oct; 59(7):913-9.
    View in: PubMed
    Score: 0.446
  11. Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis. 2014 Apr; 58(8):1125-8.
    View in: PubMed
    Score: 0.430
  12. Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 2013 Sep 23; 31(41):4564-8.
    View in: PubMed
    Score: 0.416
  13. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population. J Infect Dis. 2012 Jul 15; 206(2):190-6.
    View in: PubMed
    Score: 0.384
  14. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012 May; 271(5):510-20.
    View in: PubMed
    Score: 0.370
  15. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine. 2011 May 09; 29(20):3628-32.
    View in: PubMed
    Score: 0.353
  16. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011 Jan 12; 305(2):160-6.
    View in: PubMed
    Score: 0.348
  17. Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2023 Feb 01; 192(2):205-216.
    View in: PubMed
    Score: 0.201
  18. Family history of zoster and risk of developing herpes zoster. Int J Infect Dis. 2018 Jan; 66:99-106.
    View in: PubMed
    Score: 0.140
  19. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination. Mayo Clin Proc. 2015 Jul; 90(7):865-73.
    View in: PubMed
    Score: 0.118

© 2024 Kaiser Permanente